Hepatitis B virus infection remains one of the leading causes of liver disease, including cirrhosis and hepatocellular carcinoma.

It’s time to shine a light on the next wave of drug discovery.

Researchers at Case Western Reserve University have discovered molecules that present the potential to drive the development ...

Swiss start-up Haya Therapeutics has formed a partnership with Eli Lilly – worth up to $1 billion – to look for new therapies for obesity in non-coding DNA. The biotech focuses on trawling the ...

Chronic hepatitis B virus (HBV) infection continues to pose a major global health threat. The virus evades immune responses and antiviral therapies due to the persistence of covalently closed circular ...

With further testing, discovery may offer new target for early detection and treatmentResearchers at Case Western Reserve ...

Researchers at Case Western Reserve University have discovered molecules that present the potential to drive the development of gastric cancer-among the world's deadliest forms of the disease.

LncRNAs and circRNAs are key regulators of gene expression, influencing disease mechanisms and offering potential as ...

Fathers' stress experiences leave biochemical markers in their sperm, influencing their future children's development. The ...

Novel technology enables discovery, which could help predict tumour recurrence Researchers from the Fred Hutch Cancer Centre, ...